Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Illumina, Inc. (ILMN) vs Mettler-Toledo International, Inc. (MTD)

Illumina, Inc. and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Illumina, Inc. is the larger, with a market value of $41.3B against $30.4B — 1.4× the size. Mettler-Toledo International, Inc. trades at the lower P/E: 33.9× against 50.4×. Mettler-Toledo International, Inc. grew revenue faster over the last twelve months: 6.91% against 4.88%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 18.4%) and the higher return on invested capital (35.4% vs 17.5%). Across the 22 metrics below, Mettler-Toledo International, Inc. leads on 14 and Illumina, Inc. on 8.

Valuation

Metric ILMN MTD Diagnostics & Research median
P/E 50.39 33.94 33.95
P/S 9.16 7.36 4.87
P/B 14.50 2,372.01 3.12
Price to free cash flow 44.94 35.21 34.02
EV/EBITDA 35.99 24.88 25.20
EV/Sales 9.25 7.86 5.66
Earnings yield 1.98% 2.95% (1.75%)
Free cash flow yield 2.23% 2.84% (0.13%)

Profitability

Metric ILMN MTD Diagnostics & Research median
Gross margin 66.39% 60.26% 50.89%
Operating margin 19.65% 28.41% (8.57%)
Net margin 18.36% 21.91% (6.37%)
Free cash flow margin 20.72% 20.90% 0.00%
Return on equity 32.38% (736.36%) (2.92%)
Return on assets 12.95% 25.61% (6.71%)
Return on invested capital 17.46% 35.40% 0.00%

Growth

Metric ILMN MTD Diagnostics & Research median
Revenue growth (TTM) 4.88% 6.91% 7.69%
EPS growth (last fiscal year) 170.87% 3.88% —
Revenue growth, 5-year CAGR 6.04% 5.47% 7.40%
Net income growth, 5-year CAGR 5.32% 7.60% 0.00%

Health

Metric ILMN MTD Diagnostics & Research median
Debt to equity 0.53 164.70 0.11
Current ratio 1.80 1.12 2.02
Net debt to EBITDA (0.13) 1.68 0.78

Dividend

Metric ILMN MTD Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ILMN MTD Diagnostics & Research median
Market cap 41.25b 30.44b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack